Generic drug manufacturer Dr. Reddy’s Labs reported third quarter revenues in the U.S. that fell by 0.3% on a year earlier. The company cites declining prices as a major factor, which can also be seen in the 13.6% drop in average import values per gram for U.S. imports of all pharmaceuticals. ... Read more →


